Drugs / CD34+, CD133+, CD271+ stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02709876 | Apr 2014 → Sep 2020 | retinitis pigmentosa | Stem Cells Arabia | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+, CD133+, CD271+ stem cells | “Bone marrow-derived CD34+, CD133+, CD271+ stem cells in 1.0 ml normal saline will be injected into the vitreous cavity.” NCT02709876 ↗ |